MOLINA ARTURO MD (Chief Medical Officer) sold 15.1% of their position (15K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $1.57M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/27/2026ACC: 0001104659-26-036319
Officer· Chief Medical Officer
Since Jan 2026
-15K
Net shares
Net seller
$1.57M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$8.04
Trade value
$120.60K
% of position
17.8%
3/26/2026
84.11K→99.11K
Common Stock
Direct
Shares
−15K
Price / share
$104.79
Trade value
$1.57M
% of position
15.1%
3/26/2026
99.11K→84.11K
Total
Net shares
+0.00
Net value
-$1.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2026 | M · Option Exercise | +15K | $8.04 | $120.60K | 17.8% | 84.11K | 99.11K |
| Common Stock Direct | 3/26/2026 | S · Sale | −15K | $104.79 | $1.57M | 15.1% | 99.11K | 84.11K |
| Total | +0.00 | -$1.45M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
8.04
Held after
50.97K
Exercisable
—
3/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock15K shares | 3/26/2026 | M · Option Exercise | −15K | 8.04 | — | 50.97K |